Dr. Dario Siniscalco is biochemist for the Department of Experimental Medicine of the Second University of Naples (SUN), Italy.

 

He graduated in Chemistry from the University of Naples “Federico II” in 2000 and received his Ph.D. in Pharmacological Sciences from SUN in 2004. He completed his neuropathology fellowship at University of Alabama at Birmingham, USA before joining the Second University of Naples staff in 2006.

 

He is registered member of the following scientific societies: Order of the Chemists of Campania, National Council for Chemistry, Stem Cell Research Italy, International Association of Neurorestoratology, European Association for Chemical and Molecular Sciences, Italian Pharmacological Society, Cell Death Research Group - University of Alabama at Birmingham, USA.

 

In 2010, in collaboration with dr. Nicola Antonucci, he founded a research group to study cellular and molecular changes in autism spectrum disorders. Author or co-author of 65 scientific peer-reviewed papers and 9 book chapters.

His works received more than 1100 citations so far (h-index 21).

Presented  95 communications/abstracts to national and international conferences. He is serving as an editorial board member and reviewer of more than 40 international journals.

 

His main research interests: gene expression and molecular regulation in autism spectrum disorders; use of stem cells as therapeutic tool in autism; role of macrophage activation in autism.

 

Other research interests: stem cells therapy for the neuronal recovery; studying of neuronal apoptosis. Role of  bcl-2 family, caspases, and cell cycle regulator genes.

 

He has been nominated as Editor-in-Chief of the international peer-reviewed journal Autism OpenAccess, Omics group.

 

Full publication list is here.

 

Phone (Lab): +39 (0)81 5667532

Phone (Office): +39 (0)81 5665880

Fax: +39 (0)81 5667503

Mobile: +39 339 7468956

Mail: taodar@yahoo.it,

Mail 2: dariosin@uab.edu

Dr. Angela Racanelli graduated in Pharmacy at the University of Bari.

She later specialized in Clinical Chemistry at the University of Camerino, in Herbalism at the University of Bari and in Cosmetics Chemistry at the Sinerga in Pero-Milano, a course taught by the distinguished Prof. Proserpio.

Once formulated, she has worked with the Department of Dermatology in the Di Venere Hospital of Bari.

 

www.heliantus.it

Professor Marco Ruggiero MD obtained his Medical Doctorate in Italy in 1980 and a PhD in Molecular Biology in 1987.

 

He has published more than 100 papers in peer-reviewed scientific journals and presented his results at world conferences and congresses.

In his presentation, Prof. Ruggiero will present original, unpublished data concerning the effects of GcMAF in human cancer cells, and discuss its use in autism, ME/CFS and other diseases. He will also present data concerning the nutritional approach to cancer and chronic diseases and the relationship between nutrition and immune system activation.

 

Professor Marco Ruggiero MD obtained his Medical Doctorate in Italy in 1980, and served in the Army as Medical Officer involved in biological and chemical defence.

 

He obtained a PhD in Molecular Biology in 1987 and a specialization in Diagnostic Radiology in 1996.

 

At Burroughs Wellcome C. USA in 1984-86, as a post-doctoral fellow, he published a seminal paper on protease inhibitors with Nobel Laureate Sir John Vane ( PNAS 1986;83:3456-9). In 1987-91 was senior researcher at the National Cancer Institute of the NIH (USA), focussing on oncogenes and signal transduction and publishing papers in journals such as Science, Oncogene, Molecular and Cellular Biology, Blood and EMBO Journal.

 

On his return in Italy, he worked at one of the major Italian pharmaceutical companies (Sigma-Tau) and then became professor of Molecular Biology at the University of Firenze. Prof. Ruggiero published more than 100 papers in peer-reviewed scientific journals and presented his results at world conferences and congresses.

He received several scientific awards and grants for research including one defined as "of National Interest" (PRIN 2009). The research of Prof. Ruggiero in the past 20 years has been focussed on the vitamin D axis that includes vitamin D, its receptor and vitamin-D-binding protein from which a most powerful immune system stimulator termed GcMAF derives. Prof. Ruggiero published 4 articles in past 2 years on immunotherapy through GcMAF, and presented his results together with Prof. Yamamoto (the discoverer of GcMAF) at the World Conference on AIDS in Vienna in 2010.

 

Quite recently Prof. Ruggiero demonstrated that systemic inflammation and nutritional status are associated with the course of chronic diseases through the involvement of the immune system and this observation paves the way at treating chronic conditions ranging from cancer to HIV infection, chronic fatigue syndrome and autism through a combination of rebalanced nutrition and immune system stimulation (Am. J. Immunol. 2012; 8:65-70).

 

In his presentation, Prof. Ruggiero will present original, unpublished data concerning the effects of GcMAF in human cancer cells of different origin as well as clinical data collected from physicians using GcMAF in their patients. He will also present data concerning the nutritional approach to cancer and chronic diseases and the relationship between nutrition and immune system activation. Finally, he will present an original, simple and non invasive ultrasonographic technique to detect brain inflammation and neuronal abnormalities in chronic fatigue syndrome, autism and neurodegenerative diseases, a tool that can be exploited for the diagnosis and treatment of these conditions.

Kenny de Meirleir is a professor of physiology and internal medicine at the Vrije Universiteit Brussel in Belgium.

 

He is best known for his work on the chronic fatigue syndrome (also known as ME/CFS), including the book Chronic Fatigue Syndrome: A Biological Approach (2002) which he co-edited with Patrick Englebienne.

De Meirleir graduated in medicine from The Free University of Brussels in 1977.

 

He researches chronic fatigue syndrome and has created two tests: a breath test  to diagnose overgrowth of bacteria in the gut and a urine test to detect high levels of hydrogen sulfide. The test is related to the diagnosis and treatment of CFS/ME.

Especially the hydrogen sulfide test is very controversial, but neither test has received independent validation.

 

He treats ME-patients both at his clinic in Belgium, Himmunitas and in different cities around Europe.

There is a wiki web site that describes his approach. The same site also gathers evidential support for many of his and others methods.

 

Kenny de Meirleir is among the authors of over 80 published scientific articles, most of them related to CFS/ME. De Meirleir received the Solvay Prize in 1980 and a NATO research award for work in exercise physiology and metabolism in exercise.

 

Pubblications:

• Kenny De Meirleir, Patrick Englebienne, Chronic Fatigue Syndrome: A Biological Approach (2002),
• Kenny De Meirleir, Neil Mcgregor, Pediatric Chronic Fatigue Syndrome (2007),
• Michel Osteaux, Kenny de Meirleir, Magnetic Resonance Imaging and Spectroscopy in Sports Medicine (1991).